Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas.

Molecular biology reports - 1 Feb 2012

Silan Fatma, Gultekin Yener, Atik Sinem, Kilinc Davran, Alan Cabir, Yildiz Fazilet, Uludag Ahmet, Ozdemir Ozturk

Abstract excerpt

Prostate cancer is a common malignancy that develops by structural mutation(s) and/or other genetic alterations in specific genes.The G to T transversions in codon 12 and C to T transitions in codon 13 of KRAS proto-oncogene are predominant point mutations that occur in about 20% of different cancers in human. In the current study it was aimed to investigate the prevalence and predictive significance of KRAS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Point Mutation
Share to Prevalence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Prostatic Neoplasms

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 21607617
DOI: 10.1007/s11033-011-0898-8

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas.PMID 21607617Read ↗

Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.Semantic proximity Read ↗

Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.Semantic proximity Read ↗

BRAF and KRAS mutations in prostatic adenocarcinoma.Semantic proximity Read ↗

New monoallelic combination of KRAS gene mutations in codons 12 and 13 in the lung adenocarcinoma.Semantic proximity Read ↗

Mutational Status of Codons 12 and 13 of the N- andK-rasGenes in Tissue and Cell Lines Derived from Primary and Metastatic Prostate CarcinomasSemantic proximity Read ↗

EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer.Semantic proximity Read ↗

Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines.Semantic proximity Read ↗

KRAS and BRAF mutations in prostate carcinomas of Chinese patients.Semantic proximity Read ↗

ras gene mutations in human prostate cancer.Semantic proximity Read ↗

Application of pyrosequencing technique for improved detection of K-Ras mutation in formalin-fixed and paraffin-embedded prostate carcinoma tissues in Chinese patients.Semantic proximity Read ↗

The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.Semantic proximity Read ↗

[KRAS gene mutation in colorectal cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.